Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
1
-
641por Badamchi-Zadeh, Alexander, McKay, Paul F., Holland, Martin J., Paes, Wayne, Brzozowski, Andrzej, Lacey, Charles, Follmann, Frank, Tregoning, John S., Shattock, Robin J.“…METHODS: We used a range of heterologous prime-boost vaccinations with DNA, Adenovirus, modified vaccinia Ankara (MVA) and protein vaccines based on the major outer membrane protein (MOMP) as an antigen, and investigated the effect of vaccine route, antigen and regimen on the induction of anti-chlamydial antibodies detectable in the ocular lavage fluid of mice. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
642por Parra, Marcela, Liu, Xia, Derrick, Steven C., Yang, Amy, Molina-Cruz, Alvaro, Barillas-Mury, Carolina, Zheng, Hong, Thao Pham, Phuong, Sedegah, Martha, Belmonte, Arnel, Litilit, Dianne D., Waldmann, Thomas A., Kumar, Sanjai, Morris, Sheldon L., Perera, Liyanage P.“…Here we describe the development and characterization of a novel modified vaccinia virus Ankara (MVA)–based malaria vaccine which co-expresses the Plasmodium yoelii circumsporozoite protein (CSP) and IL-15. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
643por Yılmazlar, Firdevs, Karabayırlı, Safinaz, Gözdemir, Muhammet, Usta, Burhanettin, Peker, Murat, Namuslu, Mehmet, Erdamar, Hüsamettin“…METHODS: A prospective study was conducted on 40 patients who presented to the Department of General Surgery, Medical Faculty, Turgut Özal University, Ankara, Turkey scheduled for laparoscopic cholecystectomy operation during a 10 month period from September 2012 to June 2013. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
644“…The modified vaccinia ankara virus-expressing antigen 85A (MVA85A) aims to boost BCG immunity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
645por Kankaya, Yüksel, Oruç, Melike, Sungur, Nezih, Aslan, Özlem çolak, Gürsoy, Koray, Özer, Kadri, Koçer, Uğur“…METHODS: Thirteen patients whose medical records became available during the follow-up period at Ankara Training and Research Hospital from January 2010 to January 2015 were included in this study. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
646por Schmeisser, Falko, Jing, Xianghong, Joshi, Manju, Vasudevan, Anupama, Soto, Jackeline, Li, Xing, Choudhary, Anil, Baichoo, Noel, Resnick, Josephine, Ye, Zhiping, McCormick, William, Weir, Jerry P.“…METHODS: We previously described an alternative approach for generating strain‐specific potency antisera, utilizing modified vaccinia virus Ankara vectors to produce influenza hemagglutinin (HA)‐containing virus‐like particles (VLPs) for immunization. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
647por Meseda, Clement A., Atukorale, Vajini, Kuhn, Jordan, Schmeisser, Falko, Weir, Jerry P.“…The modified vaccinia virus Ankara is licensed as a smallpox vaccine in Europe and Canada and currently undergoing clinical development in the United States. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
648“…METHODS: A cross-sectional study was conducted with second (286; 83.1%) and third (275; 80.2%) year students at the Ankara University School of Medicine. The SRL perception (SRLP) scale and self-efficacy for problem-based learning (SPBL) scale were used in the study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
649por Badamchi-Zadeh, Alexander, McKay, Paul F., Korber, Bette T., Barinaga, Guillermo, Walters, Adam A., Nunes, Alexandra, Gomes, João Paulo, Follmann, Frank, Tregoning, John S., Shattock, Robin J.“…This consensus MOMP transgene was delivered using plasmid DNA, Human Adenovirus 5 (HuAd5) or modified vaccinia Ankara (MVA) vectors with or without MF59(®) adjuvanted recombinant MOMP protein. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
650por Jongwe, Tsungai Ivai, Chapman, Ros, Douglass, Nicola, Chetty, Shivan, Chege, Gerald, Williamson, Anna-Lise“…Mycobacterium bovis BCG ΔpanCD auxotroph and modified vaccinia Ankara (MVA) vaccines expressing HIV-1C mosaic Gag (Gag(M)) were tested in a prime-boost regimen to demonstrate immunogenicity in a mouse study. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
651por Mutua, Gaudensia, Farah, Bashir, Langat, Robert, Indangasi, Jackton, Ogola, Simon, Onsembe, Brian, Kopycinski, Jakub T, Hayes, Peter, Borthwick, Nicola J, Ashraf, Ambreen, Dally, Len, Barin, Burc, Tillander, Annika, Gilmour, Jill, De Bont, Jan, Crook, Alison, Hannaman, Drew, Cox, Josephine H, Anzala, Omu, Fast, Patricia E, Reilly, Marie, Chinyenze, Kundai, Jaoko, Walter, Hanke, Tomáš, HIV-CORE 004 study group, the“…Our first clinical trial in low risk HIV-1-negative adults in Oxford demonstrated the principle that naturally mostly subdominant epitopes, when taken out of the context of full-length proteins/virus and delivered by potent regimens involving combinations of simian adenovirus and poxvirus modified vaccinia virus Ankara, can induce robust CD8(+) T cells of broad specificities and functions capable of inhibiting in vitro HIV-1 replication. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
652“…SETTING: Eye Clinic, Baskent University Faculty of Medicine, Ankara, Turkey. DESIGN: Observational cross-sectional study and evaluation of a new diagnostic technology. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
653por Ohmer, Michaela, Weber, Arnim, Sutter, Gerd, Ehrhardt, Katrin, Zimmermann, Albert, Häcker, Georg“…During infection of epithelial cells and fibroblasts with modified vaccinia virus Ankara (MVA), Mcl-1 protein levels dropped but the MVA Bcl-2-like protein F1L could replace Mcl-1 functionally; a similar activity was found in vaccinia virus (VACV)-infected cells. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
654por Longley, Rhea J., Halbroth, Benedict R., Salman, Ahmed M., Ewer, Katie J., Hodgson, Susanne H., Janse, Chris J., Khan, Shahid M., Hill, Adrian V. S., Spencer, Alexandra J.“…PfUIS3 was expressed in the viral vectors chimpanzee adenovirus 63 (ChAd63) and modified vaccinia virus Ankara (MVA) and used to immunize mice in a prime-boost regimen. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
655por Bliss, Carly M., Drammeh, Abdoulie, Bowyer, Georgina, Sanou, Guillaume S., Jagne, Ya Jankey, Ouedraogo, Oumarou, Edwards, Nick J., Tarama, Casimir, Ouedraogo, Nicolas, Ouedraogo, Mireille, Njie-Jobe, Jainaba, Diarra, Amidou, Afolabi, Muhammed O., Tiono, Alfred B., Yaro, Jean Baptiste, Adetifa, Uche J., Hodgson, Susanne H., Anagnostou, Nicholas A., Roberts, Rachel, Duncan, Christopher J.A., Cortese, Riccardo, Viebig, Nicola K., Leroy, Odile, Lawrie, Alison M., Flanagan, Katie L., Kampmann, Beate, Imoukhuede, Egeruan B., Sirima, Sodiomon B., Bojang, Kalifa, Hill, Adrian V.S., Nébié, Issa, Ewer, Katie J.“…T cell responses peaked 7 days after boosting with modified vaccinia virus Ankara (MVA), with highest responses in infants aged 10 weeks at priming. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
656por Kocaoglu, Bike, Moschonis, George, Dimitriou, Maria, Kolotourou, Maria, Keskin, Yasar, Sur, Haydar, Hayran, Osman, Manios, Yannis“…METHODS: In three major metropolises in Turkey (Istanbul, Ankara and Izmir), a random sample of 1044 children aged 12 and 13 years old was examined. …”
Publicado 2005
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
657“…The data sets were constructed and published at Bilkent University of Ankara, Turkey. In addition, the second version of the self-developed software “XMLRULE” was used; the software can infer more than one class and facilitate the interpretability of the obtained results. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
658por Bunyasi, E. W., Luabeya, A. K. K., Tameris, M., Geldenhuys, H., Mulenga, H., Landry, B. S., Scriba, T. J., Schmidt, B-M., Hanekom, W. A., Mahomed, H., McShane, H., Hatherill, M.“…OBJECTIVE: To evaluate the long-term effectiveness of infant modified vaccinia Ankara virus-expressing antigen 85A (MVA85A) vaccination against tuberculosis (TB). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
659por Greenier, Jennifer L, Van Rompay, Koen KA, Montefiori, David, Earl, Patricia, Moss, Bernard, Marthas, Marta L“…We previously demonstrated that immunization of infant rhesus macaques with either modified vaccinia virus Ankara (MVA) expressing SIV Gag, Pol and Env, or live-attenuated SIVmac1A11 resulted in lower viremia and longer survival compared to unimmunized controls after oral challenge with virulent SIVmac251 (Van Rompay et al., J. …”
Publicado 2005
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
660por Mahant, Aakash, Saubi, Narcís, Eto, Yoshiki, Guitart, Núria, Gatell, Josep Ma, Hanke, Tomáš, Joseph, Joan“…The BCG.HIVA(2auxo.int) vaccine in combination with modified vaccinia virus Ankara (MVA).HIVA was found to be safe and induced HIV-1 and Mycobacterium tuberculosis-specific interferon-γ-producing T-cell responses in adult BALB/c mice. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto